Chlamydia pneumoniae and atherosclerotic cardiovascular disease

Clinical Microbiology Newsletter

Volumn 21, Issue 18, 1999, Pages 145-148

  Starr, Jacqueline R ^a   Jackson, Lisa A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CEPHALOSPORIN DERIVATIVE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ROXITHROMYCIN; TETRACYCLINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; ATHEROSCLEROTIC PLAQUE; CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE COURSE; HUMAN; IN VITRO STUDY; MOUSE; NONHUMAN; RABBIT; REVIEW; SEROEPIDEMIOLOGY;

EID: 0033568792     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-4399(00)89203-X     Document Type: Article

References (18)

1. Gibbs, R.G.J., N. Carey, and A.H. Davies. 1998. Chlamydia pneumoniae and vascular disease. Br. J. Surg. 85:1191-1197.
2. Jackson, L.A. et al. 1997. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J. Infect. Dis. 176:292-295.
3. Jackson, L.A. et al. 1997. Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: Evaluation of the innocent bystander hypothesis. Am. J. Pathol. 150:1785-1790.
4. Saikku, P. et al. 1988. Serologic evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet ii:983-986.
5. Danesh, J., R. Collins, and R. Peto. 1997. Chronic infections and coronary heart disease: Is there a link? Lancet 350:430-436.
6. Ridker, P.M. et al. 1999. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction. Circulation 99:1161-1164.
7. Moazed, T.C. et al. 1997. Murine models of Chlamydia pneumoniae infection and atherosclerosis. J. Infect. Dis. 175:883-890.
8. Muhlestein, J.B. et al. 1998. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 97:633-636.
9. Libby P. 1996. Atheroma: More than mush. Lancet 348(1S):4s-7s.
10. Gaydos, C.A. et al. 1996. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect. Immun. 64:1614-1620.
11. Fryer, R.H. et al. 1997. Chlamydia species infect human vascular endothelial cells and induce procoagulant activity. J. Invest. Med. 45:168-174.
12. Kalayoglu, M.V. and G.I. Byrne. 1998. A Chlamydia pneumonaie component that induces macrophage foam cell formation is chlamydial lipopolysaccharide. Infect. Immun. 66:5067-5072.
13. Kol, A. et al. 1998. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation 98:300-307.
14. Bachmaier, K. et al. 1999. Chlamydia infections and heart disease linked through antigenic mimicry. Science 283:1335-1339.
15. Meier, C.R. et al. 1999. Antibiotics and risk of subsequent first-time acute myocardial infarction. JAMA 281:427-431.
16. Jackson, L.A. et al. 1999. Lack of association between first myocardial infarction and past use of erythromycin, tetracycline, or doxycycline. Emerging Infect. Dis. 5:281-284.
17. Gupta, S. et al. 1997. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 96:404-407.
18. Gurfinkel, E. et al. 1997. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet 350:404-407.